Following the patent expiry, Novo Nordisk has also recalibrated its pricing strategy, cutting prices of Ozempic and Wegovy to an effective daily cost of Rs 202, or about Rs 1,415 per week, to remain competitive against generics
Neither of the two drugs is objectively better, as it all depends on your health goals and how your body responds to treatment
Regulatory bodies may require a dedicated cardiovascular outcomes trial before or after full approval is granted consistent with the precedent set for other agents in this class though the precise regulatory requirements will be determined by the MHRA and EMA based on the totality of evidence submitted
Patients should disclose their complete medical history, including all cancer diagnoses, to ensure appropriate treatment selection
In several of these studies sleep deprivation resulted in delayed postprandial GLP-1 response compared to normal sleep [48, 50, 51]
Toni N, Laplagne DA, Zhao C, Lombardi G, Ribak CE, Gage FH, et al